Cell Host & Microbe Acceptance Rate
Cell Host & Microbe's acceptance rate in context, including how selective the journal really is and what the number leaves out.
Journal evaluation
Want the full picture on Cell Host & Microbe?
See scope, selectivity, submission context, and what editors actually want before you decide whether Cell Host & Microbe is realistic.
What Cell Host & Microbe's acceptance rate means for your manuscript
Acceptance rate is one signal. Desk rejection rate, scope fit, and editorial speed shape the realistic path more than the headline number.
What the number tells you
- Cell Host & Microbe accepts roughly ~12% of submissions, but desk rejection accounts for a disproportionate share of early returns.
- Scope misfit drives most desk rejections, not weak methodology.
- Papers that reach peer review face a higher bar: novelty and fit with editorial identity.
What the number does not tell you
- Whether your specific paper type (review, letter, brief communication) faces the same rate as full articles.
- How fast you will hear back — check time to first decision separately.
- What open access publishing will cost if you choose that route.
Quick answer: there is no strong official Cell Host & Microbe acceptance-rate number you should treat as exact. The better submission question is whether the study reveals a host-pathogen or microbiome mechanism with clear infection or disease relevance. With a JCR 2024 impact factor of ~18-21, Cell Host & Microbe is the leading Cell Press journal for infection biology - but the editorial bar is about mechanistic insight at the host-microbe interface, not just pathogen characterization.
If the paper studies a pathogen in isolation without addressing the host response, or examines host immunity without a clear microbe angle, the acceptance-rate discussion is mostly noise. The interaction is the real issue.
How Cell Host & Microbe's Acceptance Rate Compares
Journal | Acceptance Rate | IF (2024) | Review Model |
|---|---|---|---|
Cell Host & Microbe | Not disclosed | 18-21 | Novelty |
Nature Microbiology | ~8-12% | 19.4 | Novelty |
Immunity | Not disclosed | 26.3 | Novelty |
mBio | ~25-30% | 5.1 | Soundness |
Journal of Experimental Medicine | ~15-20% | 10.6 | Novelty |
What you can say honestly about the acceptance rate
Cell Press does not publish an official acceptance rate for Cell Host & Microbe.
Third-party aggregators report estimates that vary, but none have been confirmed by the publisher. The journal's impact factor and position as the Cell Press flagship for host-microbe biology are consistent with selective publishing, but the specific number is not public.
What is stable is the editorial model:
- Cell Press uses professional PhD-trained editors who triage manuscripts, not external academic editors
- the journal's scope is the interaction between host and microbe - both sides must be addressed
- microbiome studies are welcome when they connect microbial composition to host biology mechanistically
- the editorial team values in vivo evidence and multi-model validation for infection phenotypes
That focus on the interaction - not the host alone or the pathogen alone - is the real editorial filter.
What the journal is really screening for
At triage, the editor is usually asking:
- does this study address the interaction between a host and a microbe, not just one side?
- is there a mechanistic advance beyond descriptive characterization?
- does the finding have clear relevance to infection, disease, or microbiome-driven physiology?
- is the evidence functional, not just correlative or sequencing-based?
Papers that address the host-microbe interface with mechanistic depth will survive triage more reliably than papers that study pathogens or immunity in isolation.
The better decision question
For Cell Host & Microbe, the useful question is:
Does this study reveal a mechanism at the host-microbe interface that matters for infection biology or microbiome-driven disease?
If yes, the journal is a strong fit. If the paper is fundamentally an immunology study with a pathogen as a tool, or a microbiology study without host-side investigation, the acceptance rate is not the constraint. The scope is.
Where authors usually get this wrong
The common misses are:
- centering strategy around an unofficial percentage instead of checking scope fit
- submitting pathogen-only studies without host biology
- submitting microbiome 16S profiling without mechanistic follow-up
- presenting immunity work where the host response is the advance and the microbe is incidental
- ignoring the Cell Press transfer cascade - some manuscripts arrive from Cell with prior reviewer expectations
Those are scope and evidence problems before they are rate problems.
What to use instead of a guessed percentage
If you are deciding whether to submit, these pages are more useful than an unofficial rate:
- Cell Host & Microbe cover letter
- Cell Host & Microbe submission process
- Clinical Infectious Diseases acceptance rate (IDSA flagship, clinical focus)
- Frontiers in Immunology acceptance rate (broader, higher acceptance)
Together, they tell you whether the paper sits at the right interface, whether the editorial requirements are manageable, and whether a different infection or microbiome venue would be a cleaner first submission.
Submit if / Think twice if
Submit if:
- the paper reveals a mechanism at the host-pathogen or host-microbiome interface: how a pathogen subverts host immunity, how a microbiome metabolite shapes host physiology, or how host genetic variation determines infection outcome
- the mechanistic finding has clear disease relevance: infection biology with translation to understanding or treating human disease, microbiome biology connected to host health or disease susceptibility
- the advance is broadly significant to infection and microbiome biology: researchers studying different pathogens or different host-microbe systems would find it conceptually useful
- in vivo or patient-relevant evidence supports the mechanism: cell line demonstrations with a mouse model or patient-derived data for the key mechanistic claims
Think twice if:
- the study characterizes a pathogen in isolation without addressing the host response or the host-pathogen interaction
- the host immunity study does not include a microbe component or an infectious disease context
- Cell presents a more appropriate flagship context for a result with broader significance beyond host-microbe biology
- Nature Microbiology is the right target for microbiology results not centered on the host interaction
Readiness check
See how your manuscript scores against Cell Host & Microbe before you submit.
Run the scan with Cell Host & Microbe as your target journal. Get a fit signal alongside the IF context.
What Pre-Submission Reviews Reveal About Cell Host & Microbe Submissions
In our pre-submission review work evaluating manuscripts targeting Cell Host & Microbe, three patterns generate the most consistent desk rejections. Each reflects the journal's scope: mechanistic biology of host-pathogen and host-microbiome interactions with clear disease relevance.
Pathogen characterization paper without host interaction data. The Cell Host & Microbe editorial focus is described as "the interaction between microorganisms and their hosts." The failure pattern is a paper characterizing a pathogen's structure, genetics, or virulence factors without establishing how the pathogen interacts with the host immune system or host cells. A comprehensive structural characterization of a new virulence factor, a genomic analysis of clinical isolates, or a metabolomics study of pathogen culture conditions without any host cell or animal model data does not constitute a host-microbe interaction paper in Cell Host & Microbe's sense. The journal is not a microbiology journal; it is an infection biology journal. Papers where the host is absent or appears only as a distant application mention are desk-rejected and redirected to PNAS, Nature Microbiology, or mBio.
Microbiome association study without mechanistic insight. Cell Host & Microbe publishes microbiome biology, but the standard requires mechanistic understanding of how the microbiome affects the host. The failure pattern is a paper documenting a correlation between microbiome composition and a host phenotype without establishing the mechanism. A 16S sequencing study showing that patients with condition X have different microbiome profiles than healthy controls, a shotgun metagenomics study identifying differentially abundant species in a disease cohort without functional experiments, or an observational dietary intervention study showing microbiome changes without connecting them to a host biological mechanism generates desk rejections at Cell Host & Microbe. The editors ask: what does the host cell actually do when exposed to the microbe or microbial product that is responsible for the phenotype? Without a mechanistic answer to that question, the paper belongs in a microbiome-focused journal with a lower bar for correlational evidence.
Cell biology paper using pathogen as a tool without infection context. Cell Host & Microbe occasionally receives excellent cell biology papers where a pathogen is used as a molecular tool to dissect a host cellular mechanism. The failure pattern is a paper where the primary scientific contribution is a new understanding of host cell biology, such as a new vesicle trafficking pathway, a new ubiquitination mechanism, or a new signaling network, and the pathogen is used as a tool to perturb the pathway rather than as the subject of infectious disease biology. These papers belong in Cell, Journal of Cell Biology, or eLife if the cellular mechanism is the contribution. Cell Host & Microbe expects that the interaction with the microbe and the disease-relevant consequence of the interaction are the scientific center of gravity. A Cell Host & Microbe submission readiness check can assess whether the host-microbe interaction framing and mechanistic depth are sufficient for Cell Host & Microbe triage.
Practical verdict
The honest answer to "what is the Cell Host & Microbe acceptance rate?" is that Cell Press does not publish one, and third-party estimates should not be treated as precise.
The useful answer is:
- yes, this is a selective host-microbe journal with a clear scope requirement
- no, a guessed percentage is not the right planning tool
- use host-microbe mechanistic depth and infection relevance as the real filter instead
If you want help pressure-testing whether this manuscript is positioned for a Cell Host & Microbe submission before upload, a Cell Host & Microbe submission readiness check is the best next step.
What the acceptance rate does not tell you
The acceptance rate for Cell Host & Microbe does not distinguish between desk rejections and post-review rejections. A paper desk-rejected in 2 weeks and a paper rejected after 4 months of review both count the same. The rate also does not reveal how acceptance varies by article type, geographic origin, or research area within the journal's scope.
Acceptance rates cannot predict your individual odds. A strong paper with clear scope fit, complete data, and solid methodology has substantially better odds than the headline number suggests. A weak paper with methodology gaps will be rejected regardless of the journal's overall rate.
A Cell Host & Microbe submission readiness check identifies the specific framing and scope issues that trigger desk rejection before you submit.
Before you submit
A Cell Host & Microbe desk-rejection risk check scores fit against the journal's editorial bar.
Frequently asked questions
No. Cell Press does not release official acceptance-rate figures for Cell Host and Microbe. The journal is selective given its impact factor, but the specific rate is not publicly available and third-party estimates should be treated as approximate.
Mechanistic insight into host-pathogen interactions or microbiome biology with clear infection or disease relevance. The editors screen for papers where the interaction between host and microbe is the central scientific question, not just one measurement.
The 2025 JCR impact factor is approximately 18 to 21, depending on the reporting period. The journal is ranked Q1 in both Microbiology and Immunology.
Cell Host and Microbe emphasizes the mechanistic biology of host-pathogen and host-microbiome interactions. Journal of Experimental Medicine and Immunity focus more on immune mechanisms. Nature Microbiology covers broader microbiology including environmental and non-host contexts. mBio serves a wider community with lower selectivity.
Sources
- 1. Cell Host & Microbe, Cell Press, Elsevier.
- 2. Cell Host & Microbe aims and scope, Cell Press.
- 3. Clarivate Journal Citation Reports, 2025 edition.
- 4. SCImago Journal & Country Rank: Cell Host & Microbe, Q1 ranking.
Before you upload
Want the full picture on Cell Host & Microbe?
Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.
These pages attract evaluation intent more than upload-ready intent.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- Is Cell Host & Microbe a Good Journal? Impact Factor, Comparison, and Fit Verdict
- Cell Host Microbe Submission Guide: What to Prepare Before You Submit
- Cell Host Microbe Review Time: What Authors Can Actually Expect
- How to Avoid Desk Rejection at Cell Host & Microbe (2026)
- Cell Host & Microbe Impact Factor 2026: Ranking, Quartile & What It Means
- Cell Host & Microbe APC and Open Access: Current Cell Press Pricing, Agreement Coverage, and Real Tradeoffs
Compare alternatives
Supporting reads
Want the full picture on Cell Host & Microbe?
These pages attract evaluation intent more than upload-ready intent.